Cardiovascular Diseases Clinical Trial
— eRehabOfficial title:
eRehab: Can Information and Communication Technology (ICT) Enhance Self-management of Cardiovascular Disease?
| Verified date | December 2014 |
| Source | University Hospital of North Norway |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Norway: Ethics Committee |
| Study type | Interventional |
Cardiovascular Diseases (CVD) according to the World Health Organization (WHO) are leading
causes of death and represent 30% of all global deaths and 48% of the deaths in Europe.
Moreover, the current trends predict increase in deaths caused by Cardiovascular Diseases
over the next years. Secondary preventive efforts can decrease mortality risk as well as
improve health among Cardiovascular Disease patients.
This study suggests an innovative approach in supporting the self-management of
Cardiovascular Disease patients after rehabilitation. The implied Randomized Controlled
Trial has two arms and aims to investigate the effectiveness of tailoring in an Information
and Communication Technology (ICT) based intervention. The tailoring will be based on
concepts derived from health psychology theories, and will contribute in their further
development. More specifically:
- Aim 1: To assess the needs of CVD rehabilitation patients that can potentially be met
through the use of ICT.
- Aim 2: To assess the effects of a tailored Internet-based intervention on maintenance
of self-management behaviors after a rehabilitation stay. Hypothesis: The intervention
group (tailored) will have higher adherence a) to the Internet-based intervention, and
b) to self-management.
- Aim 3: To assess the effect of mobile technology with activity sensors on physical
activity. Hypothesis: There will be a relationship between the data collected from
activity sensors and the self-reported physical activity levels.
| Status | Completed |
| Enrollment | 69 |
| Est. completion date | December 2014 |
| Est. primary completion date | October 2013 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - History of cardiovascular disease - Admission to the collaborating rehabilitation center Exclusion Criteria: - Technological illiteracy - Inability to access internet at home |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care
| Country | Name | City | State |
|---|---|---|---|
| Norway | Skibotn Rehabilitering | Skibotn | Troms |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital of North Norway | Helse Nord, LHL Helse |
Norway,
Antypas K, Wangberg SC. An Internet- and mobile-based tailored intervention to enhance maintenance of physical activity after cardiac rehabilitation: short-term results of a randomized controlled trial. J Med Internet Res. 2014 Mar 11;16(3):e77. doi: 10.2 — View Citation
Antypas K, Wangberg SC. E-Rehabilitation - an Internet and mobile phone based tailored intervention to enhance self-management of cardiovascular disease: study protocol for a randomized controlled trial. BMC Cardiovasc Disord. 2012 Jul 9;12:50. doi: 10.1186/1471-2261-12-50. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Duration and Intensity of Physical Activity | 1 month, 3 months and 12 months after discharge | No | |
| Secondary | Use of online intervention | 1 month after discharge | No | |
| Secondary | Use of online intervention | 3 months after discharge | No | |
| Secondary | Use of online intervention | 12 months after discharge | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|